The apoB/apoA-I ratio remained significantly related to cancer mortality (HR: 1.17; 95% CI 1.09–1.25), even after adjusting for traditional risk factors (age, sex, race, alcohol and dietary intake, smoking, BMI, dyslipidemia, hypertension, and diabetes) and CRP. Here, APOA1 is linked to metabolic syndrome.